| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |